These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. From diagnosis to therapy: The critical role of lncRNAs in hepatoblastoma. Alzahrani AK; Khan A; Singla N; Hai A; Alzahrani AR; Kamal M; Asdaq SMB; Alsalman AJ; Hawaj MAA; Al Odaini LH; Dzinamarira T; Imran M Pathol Res Pract; 2024 Aug; 260():155412. PubMed ID: 38889493 [TBL] [Abstract][Full Text] [Related]
6. A TGF-β-dominant chemoresistant phenotype of hepatoblastoma associated with aflatoxin exposure in children. Xiang X; Hao Y; Cheng C; Hu H; Chen H; Tan J; Wang Y; Liu X; Peng B; Liao J; Wang J; Xie Y; Liu J; Chen S; Xu L; Xie W; Xue R; Kuang M; Xu Z; Jiang H; Peng S Hepatology; 2024 Mar; 79(3):650-665. PubMed ID: 37459556 [TBL] [Abstract][Full Text] [Related]
7. Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response. Failli M; Demir S; Del Río-Álvarez Á; Carrillo-Reixach J; Royo L; Domingo-Sàbat M; Childs M; Maibach R; Alaggio R; Czauderna P; Morland B; Branchereau S; Cairo S; Kappler R; Armengol C; di Bernardo D Hepatology; 2024 Jul; 80(1):55-68. PubMed ID: 37729391 [TBL] [Abstract][Full Text] [Related]
8. CD47-Dependent Regulation of Immune Checkpoint Gene Expression and MYCN mRNA Splicing in Murine CD8 and Jurkat T Cells. Kaur S; Awad D; Finney RP; Meyer TJ; Singh SP; Cam MC; Karim BO; Warner AC; Roberts DD Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768931 [TBL] [Abstract][Full Text] [Related]
9. Focal adhesion kinase and its epigenetic interactors as diagnostic and therapeutic hints for pediatric hepatoblastoma. Braghini MR; De Stefanis C; Tiano F; Castellano A; Cicolani N; Pezzullo M; Tocco V; Spada M; Alaggio R; Alisi A; Francalanci P Front Oncol; 2024; 14():1397647. PubMed ID: 38947885 [TBL] [Abstract][Full Text] [Related]
11. A Human Organoid Model of Aggressive Hepatoblastoma for Disease Modeling and Drug Testing. Saltsman JA; Hammond WJ; Narayan NJC; Requena D; Gehart H; Lalazar G; LaQuaglia MP; Clevers H; Simon S Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32962010 [TBL] [Abstract][Full Text] [Related]
12. Genotypic Characteristics of Hepatoblastoma as Detected by Next Generation Sequencing and Their Correlation With Clinical Efficacy. Hu H; Zhang W; Zhi T; Li J; Wen Y; Li F; Mei Y; Huang D Front Oncol; 2021; 11():628531. PubMed ID: 34426785 [TBL] [Abstract][Full Text] [Related]
14. DNA methylation in Hepatoblastoma-a literature review. Shen G; Shen H; Zhang J; Yan Q; Liu H Ital J Pediatr; 2020 Aug; 46(1):113. PubMed ID: 32758256 [TBL] [Abstract][Full Text] [Related]
15. Hepatoblastoma: current knowledge and promises from preclinical studies. Calvisi DF; Solinas A Transl Gastroenterol Hepatol; 2020; 5():42. PubMed ID: 32632393 [TBL] [Abstract][Full Text] [Related]
16. Targeting excessive MYCN expression using MLN8237 and JQ1 impairs the growth of hepatoblastoma cells. Eberherr C; Beck A; Vokuhl C; Becker K; Häberle B; Von Schweinitz D; Kappler R Int J Oncol; 2019 May; 54(5):1853-1863. PubMed ID: 30864675 [TBL] [Abstract][Full Text] [Related]
17. The Killing of Human Neuroblastoma Cells by the Small Molecule JQ1 Occurs in a p53-Dependent Manner. Mazar J; Gordon C; Naga V; Westmoreland TJ Anticancer Agents Med Chem; 2020; 20(13):1613-1625. PubMed ID: 32329693 [TBL] [Abstract][Full Text] [Related]